Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis

Respiratory Medicine

Volumn 104, Issue 6, 2010, Pages 816-821

  Finklea, James D ^a   Khan, Gul ^b   Thomas, Sheree ^b   Song, Juhee ^b   Myers, Dennis ^b   Arroliga, Alejandro C ^b  

^a Allergy   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Bronchiectasis; FEV1 predicted; Mortality; Systemic steroids

Indexed keywords

ANTIBIOTIC AGENT; CILASTATIN PLUS IMIPENEM; CREATININE; PIPERACILLIN PLUS TAZOBACTAM; STEROID; TOBRAMYCIN; VANCOMYCIN;

AGED; ARTICLE; ARTIFICIAL VENTILATION; BRONCHIECTASIS; CIGARETTE SMOKING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL PATIENT; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; SOCIAL SECURITY; SPUTUM CULTURE; SURVIVAL TIME; COMPLICATION; DISEASE COURSE; EPIDEMIOLOGY; EVALUATION STUDY; HOSPITALIZATION; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UNITED STATES;

AGED; BRONCHIECTASIS; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TEXAS; TREATMENT OUTCOME;

EID: 77952322348     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.11.021     Document Type: Article

References (30)

1. Barker A.F. Bronchiectasis. N Engl J Med 346 (2002) 1383-1393
2. Laennec R.T.H. A treatise on the disease of the chest. [Forbes JH, Trans.] (1962), Library of the New York Academy of Medicine, Hafner Publishing, New York
3. Barker A.F., and Bardana Jr. E.J. Bronchiectasis: update of an orphan disease. Am Rev Respir Dis 137 (1988) 969-978
4. Cole P.J. Inflammation: a two-edged sword- the model of bronchiectais. Eur J Respir Dis Suppl 147 (1986) 6-15
5. Alzeer A.H., Masood M., Jani Basha S., et al. Survival of brochiectatic patients with respiratory failure in ICU. BMC Pulm Med 7 (2007) 17
6. Dupont M., Gacouin A., Lena H., et al. Survival of patients with bronchiectasis after the first ICU stay for respiratory failure. Chest 125 (2004) 1815-1820
7. Onen Z.P., Gulbay B.E., Sen E., et al. Analysis of the factors related to mortality in patients with bronchiectasis. Respir Med 101 (2007) 1390-1397
8. Steinfort D.P., Brady S., Weisinger H.S., et al. Bronchiectasis in Central Australia: a young face to an old disease. Respir Med 102 (2008) 574-578
9. Keistinen T., Säynäjäkangas O., Tuuponen T., et al. Bronchiectasis: an orphan disease with a poorly-understood prognosis. Eur Respir J 10 (1997) 2784-2787
10. O'Donnell A.E., Barker A.F., Ilowite J.S., et al. Treatment of idiopathic bronchiectasis with aerosolized recombinant human dnase I. rhDNase Study Group. Chest 113 (1998) 1329-1334
11. Dodd J.D., Souza C.A., and Müller N.L. Conventional high-resolution CT versus helical high resolution MDCT in the detection of bronchiectasis. Am J Roentgenology 187 (2006) 414-420
12. van der Bruggen-Bogaarts B.A., van der Bruggen H.M., van Waes P.F., et al. Screening for bronchiectasis. a comparative study between chest radiography and high-resolution CT. Chest 109 3 (1996) 608-611
13. Naidich D.P., McCuley D.I., Khouri N.F., et al. Computed tomography of bronchiectasis. J Comput Assist Tomogr 6 (1982) 437-444
14. Social Security Administration. Security death index. Available from: http://ssdi.genealogy.rootsweb.com/[accessed 16.10.2007].
15. Pasteur M.C., Helliwell S.M., Houghton S.J., et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 162 (2000) 1277-1284
16. Nicotra M.B., Rivera M., Dale A.M., et al. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest 108 (1995) 955-961
17. Roberts H.R., Wells A.U., Milne D.G., et al. Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function test. Thorax 55 (2000) 198-204
18. Davies G., Wells A.U., Doffman S., et al. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Eur Respir J 28 (2006) 974-979
19. Lim W.S., van der Eerden M.M., Laing R., et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58 (2003) 377-382
20. Fine M.J., Auble T.E., Yealy D.M., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336 (1997) 243-250
21. España P.P., Capelastegui A., Gorordo I., et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med 174 (2006) 1249-1256
22. Lasserson T.J., Holt K., and Greenstone M. Oral steroids for bronchiectasis (stable and acute exacerbations). Cochrane Database Syst Rev 4 (2001) CD002162
23. O'Donnell A.E. Bronchiectasis. Chest 134 (2008) 815-823
24. Niewoehner D.E., Erbland M.L., Deupree R.H., et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. New Engl J Med 340 (1999) 1941-1947
25. Martínez-García M.A., Perpiñá-Tordera M., Román-Sánchez P., et al. Inhaled steroids improve quality of life in patients with steady-state bronchiectasis. Respir Med 100 (2006) 1623-1632
26. Tsang K.W., Tan K.C., Ho P.L., et al. Inhaled fluticasone in bronchiectasis: a 12 month study. Thorax 60 (2005) 239-243
27. Vial W.C. Cigarette smoking and lung disease. Am J Med Sci 291 (1986) 130-142
28. Verr F., Escudier E., Lebargy F., et al. Cillary abnormalities in bronchial epithelium of smokers, ex smokers and nonsmokers. Am J Respir Crit Care Med 151 (1995) 630-634
29. Celli B.R., MacNee W., and ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 (2004) 932-946
30. Peinado V.I., Barberá J.A., Abat P., et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159 (1999) 1605-1611